Evaluation of the expression of integrins and cell adhesion molecules through tissue microarray in lymph node metastases of prostate cancer

Journal of Carcinogenesis

Volumn 8, Issue , 2009, Pages

  Pontes Jr , José ^a   Reis, Sabrina Thalita ^a   Dall'Oglio, Marcos ^a   de Oliviera, Luis Carlos Neves ^a   Cury, Jose ^a   Carvalho, Paul Afonso ^a   Ribeiro Filho, Leopoldo Alves ^a   Leite, Kátia Ramos Moreira ^a   Srougi, Miguel ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cell adhesion molecules; Integrins; Lymph nodes; Metastases; Prostate cancer

Indexed keywords

ALPHA3 INTEGRIN; ALPHA5 INTEGRIN; ALPHA6 INTEGRIN; BETA CATENIN; BETA4 INTEGRIN; CELL ADHESION MOLECULE; INTEGRIN; PLAKOGLOBIN; PROSTATE SPECIFIC ANTIGEN; UVOMORULIN; VERY LATE ACTIVATION ANTIGEN 2; VERY LATE ACTIVATION ANTIGEN 3; VITRONECTIN RECEPTOR;

ADULT; ARTICLE; CANCER STAGING; CANCER SURGERY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PHENOTYPE; PROSTATE ADENOCARCINOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY;

EID: 65449174848     PISSN: None     EISSN: 14773163     Source Type: Journal    
DOI: 10.4103/1477-3163.48453     Document Type: Article

References (38)

1. Albelda SM. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest 1993;68:4-17
2. Holly SP, Larson MK, Parise LV. Multiple roles of integrins in cell motility. Exp Cell Res 2000;261:69-74
3. Calderwood DA, Shattil SJ, Ginsberg MH. Integrins and actin filaments: Reciprocal regulation of cell adhesion and signaling. J Biol Chem 2000;275:22607-10.
4. Hynes RO. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25.
5. Slack-Davis JK, Parsons JT. Emerging views of integrin signaling: Implications for prostate cancer. J Cell Biochem 2004;91:41-6.
6. Plantefaber LC, Hynes RO. Changes in integrin receptors on oncogenically transformed cells. Cell 1989;56:281-90.
7. Fornaro M, Manes T, Languino LR. Integrins and prostate cancer metastases. Cancer Metastasis Rev 2001;20:321-31
8. Witkowski CM, Rabinovitz I, Nagle RB, Affinito KS, Cress AE. Characterization of integrin subunits, cellular adhesion and tumorgenicity of four human prostate cell lines. J Cancer Res Clin Oncol 1993;119:637-44.
9. Kemler R. From cadherins to catenins: Cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet 1993;9:317-21
10. Jou TS, Stewart DB, Stappert J, Nelson WJ, Marrs JA. Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex. Proc Natl Acad Sci USA 1995;92:5067-71.
11. De Marzo AM, Knudsen B, Chan-Tak K, Epstein JI. E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens. Urology 1999;53:707-13.
12. Rubin MA, Mucci NR, Figurski J, Fecko A, Pienta KJ, Day ML. E-cadherin expression in prostate cancer: A broad survey using high-density tissue microarray technology. Hum Pathol 2001;32:690-7.
13. Davis TL, Cress AE, Dalkin BL, Nagle RB. Unique expression pattern of the alpha6beta4 integrin and laminin-5 in human prostate carcinoma. Prostate 2001;46:240-8.
14. Morita N, Uemura H, Tsumatani K, Cho M, Hirao Y, Okajima E, et al. E-cadherin and alpha, beta and gamma catenin expression in prostate cancer: Correlation with tumor invasion. BJU Int 1999;79:1879-83.
15. Saha B, Arase A, Iman SS, Tsao-Wei D, Naritoku WY, Groshen S, et al. Overexpression of E-cadherin and Beta catenin proteins in metastatic prostate cancer cells in bone. Prostate 2008;68:78-84.
16. Okegawa T, Li Y, Pong RC, Hsieh JT. Cell adhesion proteins as tumor suppressors. J Urol 2002;167:1836-43.
17. Tantivejkul K, Kalikin LM, Pienta KJ. Dynamic process of prostate cancer metastasis to bone. J Cell Biochem 2004;91:706-17.
18. Cress AE, Rabinovitz I, Zhu W, Nagle RB. The alfa6beta1 and alfa6beta4 integrins in human prostate cancer progression. Cancer Metastasis Rev 1995;14:219-28.
19. Knox JD, Cress AE, Clark V, Manriquez L, Affinito KS, Dalkin BL, et al. Differential expression of extracellular matrix molecules and the alpha 6-integrins in the normal and neoplastic prostate. Am J Pathol 1994;145:167-74.
20. Von Bredow DC, Nagle RB, Bowden GT, Cress AE. Cleavage of beta4 integrin by matrilysin. Exp Cell Res 1997;236:341-5.
21. Allen MV, Smith GJ, Juliano R, Maygarden SJ, Mohler JL. Downregulation of the beta4 integrin subunit in prostatic carcinoma and prostatic intraepithelial neoplasia. Hum Pathol 1998;29:311-8.
22. Edlund M, Miyamoto T, Sikes RA, Ogle R, Laurie GW, Farach-Carson MC, et al. Integrin expression and usage by prostate cancer cell lines on laminin substrata. Cell Growth Differ 2001;12:99-107.
23. Rabinovitz I, Nagle RB, Cress AE. Integrin alpha 6 expression in human prostate carcinoma cells is associated with a migratory and invasive phenotype in vitro and in vivo. Clin Exp Metastasis 1995;13:481-91.
24. Nagle RB, Hao J, Knox JD, Dalkin BL, Clark V, Cress AE. Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue. Am J Pathol 1995;146:1498-507.
25. Su AI, Welsh JB, Sapinoso LM, Kern SG, Dimitrov P, Lapp H, et al. Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 2001;61:7388-93.
26. Schmelz M, Cress AE, Scott KM, Burger F, Cui H, Sallam K, et al. Different phenotypes in human prostate cancer: Alpha6 or alpha3 integrin in cell-extracellular adhesion sites. Neoplasia 2002;4:243-54.
27. Hangan D, Uniyal S, Morris VL, MacDonald IC, von Ballestrem C, Chau T, et al. Integrin VLA-2 (alpha2beta1) function in postextravasation movement of human rhabdomyosarcoma RD cells in the liver. Cancer Res 1996;56:3142-9.
28. Bonkhoff H, Stein U, Remberger K. Differential expression of alpha 6 and alpha 2 very late antigen integrins in the normal, hyperplastic, and neoplastic prostate: Simultaneous demonstration of cell surface receptors and their extracellular ligands. Hum Pathol 1993;24:243-8.
29. Cooper CR, Chay CH, Pienta KJ. The Role of avb3 in prostate cancer progression. Neoplasia 2002;4:191-4.
30. Cooper CR, Pienta KJ. Cell adhesion and chemotaxis in prostate cancer metastasis to bone: A minireview. Prostate Cancer Prostatic Dis 2000;3:6-12.
31. Elgavish A, Prince C, Chang PL, Lloyd K, Lindsey R, Reed R. Osteopontin stimulates a subpopulation of quiescent human prostate epithelial cells with high proliferative potential to divide in vitro. Prostate 1998;35:83-94.
32. Junior JP, Srougi M, Borra PM, Dall'Oglio MF, Ribeiro-Filho LA, Leite KR. E-cadherin and β-catenin loss of expression related to bone metastasis in prostate cancer. Appl Immunohistochem Mol Morphol 2008 Aug 5.
33. Ke XS, Goldfinger N, Rostad K, Hovland R, Akslen LA, Rotter V, et al. Epithelial to mesenchymal transition of a primary prostate cell line with switches of cell adhesion modules but without malignant transformation. PLoS One 2008;3:e3368.
34. Behrens J, Mareel MM, Van Roy FM, Birchmeier W. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 1989;108:2435-47.
35. Sommers CL, Gelmann EP, Kemler R, Cowin P, Byers SW. Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells. Cancer Res 1994;54:3544-52.
36. Barker N, Morin PJ, Clevers H. The Yin-Yang of TCF/ beta catenin signaling. Adv Cancer Res 2000;77:1-24.
37. Chen G, Shukeir N, Potti A, Sircar K, Aprikian A, Goltzman D, et al. Up-regulation of Wnt-1 and beta catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications. Cancer 2004;101:1345-56.
38. Knudsen BS, Miranti CK. The impact of cell adhesion changes on proliferation and survival during prostate cancer development and progression. J Cell Biochem 2006;99:345-61.